A Randomized, Double Blind, Multi-Center Study of Compound Danshen Dripping Pills in Patients With Diabetic Retinopathy (Syndrome Of Qi-Stagnation and Blood Stasis)

NCT02388984 Phase 3 UNKNOWN

The purpose of this study is to evaluate the efficacy and safety of Compound Danshen Dripping Pills in patients with diabetic retinopathy(Syndrome Of Qi-Stagnation and Blood Stasis).

Details

Lead sponsor	Tasly Pharmaceuticals, Inc.
Phase	Phase 3
Status	UNKNOWN
Enrolment	480
Start date	2013-05
Completion	2017-12

Conditions

• Non-proliferative Diabetic Retinopathy

Interventions

• Compound danshen dripping pills
• Placebo

Primary outcomes

• The total effective rate of Fundus changes, the severity of diabetic retinopathy change from baseline at the end of week 24 compared to placebo — 24weeks

Countries

China